Aarti Pharmalabs Ltd. (AARTIPHARM): Aarti Pharmalabs Share Price Rises 5.55% to Rs 893.45; Market Cap at Rs 7,443.45 Cr
- September 22, 2026
- Posted by: Harsh Piplani
- Category: News
Aarti Pharmalabs Share Price rose today, with the stock closing at Rs 893.45, up 5.55% from the previous close of Rs 846.45. The company’s market capitalisation stands at Rs 7,443.45 crore, and the day’s move places Aarti Pharmalabs among the Stocks in News on the Indian Stock Market. The data confirms a clear share price rise, but it does not establish a company-specific catalyst. For readers tracking Aarti Pharmalabs Share Price Today, the verified figures show a higher close, a day high of Rs 896 and turnover of Rs 2.67 crore. Univest is covering the move as an event-led stock update, with the key question now being what the numbers say about valuation, sector positioning and how this Stock News compares with peers.
At the open, the stock started at Rs 846.75 and matched its day low at the same level before moving up to the day high of Rs 896.00. That price action makes today’s gain relevant in the context of Aarti Pharmalabs Share Price Live searches, especially because no separate announcement or trigger is verified in the supplied data. Univest readers can use this note as a factual starting point for Aarti Pharmalabs Stock News, Aarti Pharmalabs News Today and broader Aarti Pharmalabs Share News coverage.
Aarti Pharmalabs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 893.45 |
| Previous Close | Rs 846.45 |
| Today's Move | Rs 47 (+5.55%) |
| Open | Rs 846.75 |
| High | Rs 896 |
| Low | Rs 846.75 |
| Turnover | Rs 2.67 crore |
| Market Capitalisation | Rs 7,443.45 crore |
| Market Cap Category | Mid Cap |
Aarti Pharmalabs Ltd. (AARTIPHARM) rose to Rs 893.45 from the previous close of Rs 846.45, a move of Rs 47 or 5.55%. The stock opened at Rs 846.75, reached a high of Rs 896, recorded a low of Rs 846.75.
Aarti Pharmalabs Share Price Today moved from Rs 846.45 at the previous close to Rs 893.45, a gain of Rs 47.00 or 5.55%. The stock opened at Rs 846.75, stayed close to that level early in the session, and reached a day high of Rs 896.00. The figures show a firm same-day price rise, with turnover at Rs 2.67 crore and no company-specific trigger established by the supplied data. For readers scanning Aarti Pharmalabs Stock Gaining Today or Top Gainers Today, the event is best understood as a verified price action update rather than a narrative built around an unconfirmed cause.
The move also matters for Aarti Pharmalabs Stock Performance because the day’s range was narrow relative to the closing gain, suggesting a session that developed around a higher finish rather than an abrupt end-of-day spike. Univest tracks such Aarti Pharmalabs Share Price Update stories by pairing the day’s move with valuation and sector context, so the event can be read in a disciplined way instead of a speculative one.
Aarti Pharmalabs Ltd. (AARTIPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 7,443.45 crore |
| P/E Ratio | 36.01x |
| P/B Ratio | 3.5x |
| ROE | 8.5% |
| ROCE | 10.77% |
| EPS | Rs 23.51 |
| Book Value Per Share | Rs 241.54 |
| Dividend Yield | 0.41% |
Aarti Pharmalabs Ltd. (AARTIPHARM) fundamental metrics show P/E 36.01x, P/B 3.5x, ROE 8.5%, ROCE 10.77%. These figures provide context only and are not a buy or sell signal.
Aarti Pharmalabs Ltd. has a market capitalisation of Rs 7443.45 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 36.01x, P/B at 3.5x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.5% and ROCE of 10.77%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 23.51, book value per share of Rs 241.54, dividend yield of 0.41%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.62x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 36.01x |
| Benchmark Median P/E | 32.62x |
| Benchmark Average P/E | 49.51x |
| Benchmark P/E Range | 3.37x to 747.32x |
| Company P/B Ratio | 3.5x |
| Benchmark Median P/B | 3x |
| Company ROE | 8.5% |
| Benchmark Median ROE | 11.74% |
| Company ROCE | 10.77% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 7,443.45 crore |
| Benchmark Median Market Cap | Rs 746.45 crore |
Aarti Pharmalabs Ltd. (AARTIPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 36.01x, which is above the benchmark median of 32.62x, a difference of +10.39%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROE of 8.5%, which is below the benchmark median of 11.74%, a difference of -27.6%. Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROCE of 10.77%, which is below the benchmark median of 13.63%, a difference of -20.98%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 37.05 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.6 | 14.18 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 86.64 | 21.05 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.67 | 4.3 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 33.19 | 3.18 | 11.83 | 16 |
Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 36.01x compared with the displayed peer median of 37.05x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.5% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 10.77% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Aarti Pharmalabs Ltd. (AARTIPHARM) has a market capitalisation of Rs 7,443.45 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Aarti Pharmalabs
- Aarti Pharmalabs Share Price rose 5.55% today to Rs 893.45.
- The stock moved from a previous close of Rs 846.45 to a day high of Rs 896.00.
- Market capitalisation stands at Rs 7,443.45 crore.
- P/E is 36.01, P/B is 3.5, ROE is 8.5 and ROCE is 10.77.
- The company’s price and valuation can be compared with Healthcare peers on Univest.
About Aarti Pharmalabs
Aarti Pharmalabs Ltd. is part of the Pharmaceuticals & Drugs industry in the Healthcare sector. The supplied data does not break out product lines, revenue mix or segment detail, so the company should be viewed here through its listed market profile: a Rs 7,443.45 crore business with earnings and book-value metrics available for public comparison. For Aarti Pharmalabs Share Price readers, that makes the stock easier to evaluate through market-based ratios than through a detailed segment map.
The company’s P/E of 36.01, P/B of 3.5, EPS of Rs 23.51 and book value of Rs 241.54 provide a basic financial frame, while ROE and ROCE show how the business is converting capital into returns. Univest tracks Aarti Pharmalabs Company News and Aarti Pharmalabs Stock Performance in this same company lens, helping readers connect today’s share price rise with the underlying listed-company profile.
Track Aarti Pharmalabs Share Price on Univest
Use Aarti Pharmalabs Ltd. (AARTIPHARM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Aarti Pharmalabs Share Price rise today?
Ans. The supplied data confirms that Aarti Pharmalabs Share Price rose 5.55% to Rs 893.45, but it does not establish a company-specific catalyst. The move is verified as a same-day price rise with a Rs 7,443.45 crore market cap.
What is Aarti Pharmalabs Share Price Today?
Ans. Aarti Pharmalabs Share Price Today is Rs 893.45. It is up Rs 47.00, or 5.55%, from the previous close of Rs 846.45, and the stock’s day high was Rs 896.00.
What is Aarti Pharmalabs market capitalisation?
Ans. Aarti Pharmalabs has a market capitalisation of Rs 7,443.45 crore. That size sits above the same-industry median in the supplied benchmark set, while remaining below the industry average shown in the data.
What are Aarti Pharmalabs valuation metrics?
Ans. Aarti Pharmalabs has a P/E ratio of 36.01 and a P/B ratio of 3.5. Its EPS is Rs 23.51 and book value is Rs 241.54, which provide context for the current share price.
How do Aarti Pharmalabs ROE and ROCE compare?
Ans. Aarti Pharmalabs reports ROE of 8.5 and ROCE of 10.77. Both are below the same-industry medians of 11.74 and 13.63, which places the stock below the benchmark midpoint on returns.
How does Aarti Pharmalabs compare with pharma peers?
Ans. Compared with peers such as Sun Pharmaceutical, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla, Aarti Pharmalabs has a smaller market cap and lower ROE and ROCE, while its P/E is near Sun Pharma’s level.
What does Aarti Pharmalabs dividend yield show?
Ans. Aarti Pharmalabs has a dividend yield of 0.41%. Dividend yield is a historical or current payout measure, so it adds context to the share price, but it does not indicate any guaranteed future distribution.
Is Aarti Pharmalabs in Healthcare or Pharmaceuticals & Drugs?
Ans. Aarti Pharmalabs belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That classification is useful for sector comparison, peer review and broader Aarti Pharmalabs Stock News tracking on Univest.
